Page 77 - 《中国药房》2026年2期
P. 77

toxicity  with  vancomycin  therapeutic  drug  monitoring   vancomycin-induced renal tubular cell apoptosis via sup‐
              guided by area under the concentration-time curve against   pression of apoptosis,mitochondrial dysfunction,and oxi‐
              a trough 15-20 μg/mL concentration[J]. Int J Antimicrob   dative stress[J]. Phytother Res,2019,33(8):2056-2063.
              Agents,2020,56(4):106109.                      [12]  HOLFORD N,O’HANLON C J,ALLEGAERT K,et al.
          [ 2 ]  何娜,苏珊,翟所迪,等. 《中国万古霉素治疗药物监测指                      A physiological approach to renal clearance:from prema‐
              南(2020 更新版)》解读[J]. 临床药物治疗杂志,2021,19                 ture neonates to adults[J]. Br J Clin Pharmacol,2024,90
              (1):12-16.                                         (4):1066-1080.
          [ 3 ]  TSUTSUURA M,MORIYAMA H,KOJIMA N,et al. The   [13]  MURPHY  M,GIRDWOOD  S  T,SCHEETZ  M  H.  Cli-
              monitoring of vancomycin:a systematic review and meta-  nical  guideline  highlights  for  the  hospitalist:therapeutic
              analyses  of  area  under  the  concentration-time  curve-  monitoring of vancomycin[J]. J Hosp Med,2020,15(12):
              guided  dosing  and  trough-guided  dosing[J].  BMC  Infect   740-742.
              Dis,2021,21(1):153.                            [14]  白一兵,赵玉,马悦,等. 中性粒细胞缺乏患者万古霉素
          [ 4 ]  RYBAK M J,LE J,LODISE T P,et al. Therapeutic moni‐  血药浓度影响因素分析[J]. 医药导报,2022,41(10):
              toring  of  vancomycin  for  serious  methicillin-resistant   1523-1527.
              Staphylococcus  aureus  infections:a  revised  consensus   [15]  WANG  H,TANG  C,DANG  Z  H,et  al.  Clinicopatholo-
              guideline and review by the American Society of Health-  gical characteristics of high-altitude polycythemia-related
              System  Pharmacists,the  Infectious  Diseases  Society  of   kidney disease in Tibetan inhabitants[J]. Kidney Int,2022,
              America,the  Pediatric  Infectious  Diseases  Society,and   102(1):196-206.
              the  Society  of  Infectious  Diseases  Pharmacists[J]. Am  J   [16]  PU L L,XU H B,WANG Z R,et al. Intermittent high alti‐
              Health Syst Pharm,2020,77(11):835-864.              tude  hypoxia  induced  liver  and  kidney  injury  leading  to
          [ 5 ]  BAIGENT C,EMBERSON J,HAYNES R,et al. Impact      hyperuricemia[J].  Arch  Biochem  Biophys,2024,758:
              of  diabetes  on  the  effects  of  sodium  glucose  co-  110078.
              transporter-2 inhibitors on kidney outcomes:collaborative   [17]  VAN BOMMEL E J M,RUITER D,MUSKIET M H A,
              meta-analysis of large placebo-controlled trials[J]. Lancet,  et al. Insulin sensitivity and renal hemodynamic function
              2022,400(10365):1788-1801.                          in metformin-treated adults with type 2 diabetes and pre‐
          [ 6 ]  WANG Q,LIU G Q,DUAN Y B,et al. Exploring cyto‐   served  renal  function[J].  Diabetes  Care,2020,43(1):
              chrome  P450  under  hypoxia:potential  pharmacological   228-234.
              significance  in  drug  metabolism  and  protection  against   [18]  CHU  Y  G,ZHOU  Y,LU  S  H,et  al.  Pathogenesis  of
              high-altitude  diseases[J].  Drug  Metab  Dispos,2025,53  higher  blood  pressure  and  worse  renal  function  in  salt-
              (2):100026.                                         sensitive hypertension[J]. Kidney Blood Press Res,2021,
          [ 7 ]  LIU J H,XIN Z B,HUANG Y Z,et al. Climate suitability   46(2):236-244.
              assessment on the Qinghai-Tibet Plateau[J]. Sci Total En‐  [19]  DUAN Y B,BAI X,YANG J X,et al. Exposure to high-
              viron,2022,816:151653.                              altitude  environment  is  associated  with  drug  transporters
          [ 8 ]  WANG S Y,GAO J,ZHAO J H. Effects of high altitude   change:microRNA-873-5p-mediated  alteration  of  func‐
              on renal physiology and kidney diseases[J]. Front Physiol,  tion and expression levels of drug transporters under hy‐
              2022,13:969456.                                     poxia[J]. Drug Metab Dispos,2022,50(2):174-186.
          [ 9 ]  SU X Y,MATTHEWS T,HILDRETH M,et al. Activa‐  [20]  BAI  X,YANG  J  X,LIU  G  Q,et  al.  Regulation  of
              tion of sympathetic nervous system contributes to erthro‐  CYP450 and drug transporter mediated by gut microbiota
              protein  gene  upregulation  by  hypobaric  hypoxia[J].   under  high-altitude  hypoxia[J].  Front  Pharmacol,2022,
              FASEB J,2022,36(S1):fasebj.2022.36.S1.R2781.        13:977370.
          [10]  QIU  F  F,SUN Y  M,LI W  B,et  al. A  review  on  drug-  [21]  LIU  D,YU  Q,LI  Z  B,et  al.  UGT1A1  dysfunction  in‐
              metabolizing enzymes,transporters,and gut microbiota on   creases  liver  burden  and  aggravates  hepatocyte  damage
              pharmacokinetics  in  high-altitude  environment[J/OL].   caused by long-term bilirubin metabolism disorder[J]. Bio‐
              Curr  Drug  Metab,2025[2025-11-15].  http:pubmed. nci.  chem Pharmacol,2021,190:114592.
              nlm.nih.gov/39931992/.                                        (收稿日期:2025-08-18  修回日期:2025-12-11)
          [11]  QU  S  Q,DAI  C  C,GUO  H,et  al.  Rutin  attenuates                              (编辑:张元媛)









          中国药房  2026年第37卷第2期                                                 China Pharmacy  2026 Vol. 37  No. 2    · 203 ·
   72   73   74   75   76   77   78   79   80   81   82